BC
Bruce & Co Portfolio holdings
AUM
$308M
1-Year Return
16.62%
This Quarter Return
-5.29%
1 Year Return
+16.62%
3 Year Return
+23.4%
5 Year Return
+75.93%
10 Year Return
+183.38%
AUM
$293M
AUM Growth
-$63.1M
(-18%)
Cap. Flow
-$55M
Cap. Flow
% of AUM
-18.73%
Top 10 Holdings %
Top 10 Hldgs %
69.39%
Holding
39
New
2
Increased
1
Reduced
21
Closed
1
Top Buys
| 1 |
Darling Ingredients
DAR
|
$3.65M |
| 2 |
Vicor
VICR
|
$1.18M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
$543K |
Top Sells
| 1 |
Merck
MRK
|
$8.2M |
| 2 |
U-Haul Holding Co Series N
UHAL.B
|
$4.34M |
| 3 |
AbbVie
ABBV
|
$4.28M |
| 4 |
Duke Energy
DUK
|
$4.1M |
| 5 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
$3.44M |
Sector Composition
| 1 | Healthcare | 34.02% |
| 2 | Utilities | 28.11% |
| 3 | Industrials | 15.07% |
| 4 | Communication Services | 6.59% |
| 5 | Financials | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caribou Biosciences
CRBU
$172M
| $956K | 0.33% |
200,000
| – | – |
|
27
Kodiak Sciences
KOD
$452M
| $851K | 0.29% |
473,000
| – | – |
|
28
MannKind Corp
MNKD
$1.64B
| $806K | 0.27% |
195,073
| – | – |
|
29
Viatris
VTRS
$12B
| $581K | 0.2% |
58,252
-1,287
| -2% | -$12.8K |
|
30
Organon & Co
OGN
$2.52B
| $541K | 0.18% |
31,190
-280
| -0.9% | -$4.86K |
|
31
908 Devices
MASS
$198M
| $455K | 0.16% |
68,286
| – | – |
|
32
Fate Therapeutics
FATE
$112M
| $424K | 0.14% |
200,000
| – | – |
|
33
RLI Corp
RLI
$6.22B
| $272K | 0.09% |
4,000
-800
| -17% | -$54.4K |
|
34
Personalis
PSNL
$451M
| $182K | 0.06% |
150,000
| – | – |
|
35
Warner Bros
WBD
$29.1B
| $129K | 0.04% |
11,851
-2,960
| -20% | -$32.1K |
|
|
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-1,556,247
| Closed | -$3.44M |
|